The role of metabotropic glutamate receptors in neurobehavioral effects associated with methamphetamine use
- PMID: 36868629
- DOI: 10.1016/bs.irn.2022.10.005
The role of metabotropic glutamate receptors in neurobehavioral effects associated with methamphetamine use
Abstract
Metabotropic glutamate (mGlu) receptors are expressed throughout the central nervous system and act as important regulators of drug-induced neuroplasticity and behavior. Preclinical research suggests that mGlu receptors play a critical role in a spectrum of neural and behavioral consequences arising from methamphetamine (meth) exposure. However, an overview of mGlu-dependent mechanisms linked to neurochemical, synaptic, and behavioral changes produced by meth has been lacking. This chapter provides a comprehensive review of the role of mGlu receptor subtypes (mGlu1-8) in meth-induced neural effects, such as neurotoxicity, as well as meth-associated behaviors, such as psychomotor activation, reward, reinforcement, and meth-seeking. Additionally, evidence linking altered mGlu receptor function to post-meth learning and cognitive deficits is critically evaluated. The chapter also considers the role of receptor-receptor interactions involving mGlu receptors and other neurotransmitter receptors in meth-induced neural and behavioral changes. Taken together, the literature indicates that mGlu5 regulates the neurotoxic effects of meth by attenuating hyperthermia and possibly through altering meth-induced phosphorylation of the dopamine transporter. A cohesive body of work also shows that mGlu5 antagonism (and mGlu2/3 agonism) reduce meth-seeking, though some mGlu5-blocking drugs also attenuate food-seeking. Further, evidence suggests that mGlu5 plays an important role in extinction of meth-seeking behavior. In the context of a history of meth intake, mGlu5 also co-regulates aspects of episodic memory, with mGlu5 stimulation restoring impaired memory. Based on these findings, we propose several avenues for the development of novel pharmacotherapies for Methamphetamine Use Disorder based on the selective modulation mGlu receptor subtype activity.
Keywords: 5-HT2a; A2a; D2 receptor; Drug-seeking; Memory; Methamphetamine; Neurotoxicity; Relapse; mGlu1; mGlu2; mGlu3; mGlu5; mGlu7; mGlu8.
Copyright © 2023 Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflict of interest The authors have no conflict of interest to report.
Similar articles
-
Cognitive effects of Group I metabotropic glutamate receptor ligands in the context of drug addiction.Eur J Pharmacol. 2010 Aug 10;639(1-3):47-58. doi: 10.1016/j.ejphar.2010.01.029. Epub 2010 Apr 2. Eur J Pharmacol. 2010. PMID: 20371237 Free PMC article. Review.
-
The metabotropic glutamate 5 receptor modulates extinction and reinstatement of methamphetamine-seeking in mice.PLoS One. 2013 Jul 4;8(7):e68371. doi: 10.1371/journal.pone.0068371. Print 2013. PLoS One. 2013. PMID: 23861896 Free PMC article.
-
A critical role of striatal A2A R-mGlu5 R interactions in modulating the psychomotor and drug-seeking effects of methamphetamine.Addict Biol. 2016 Jul;21(4):811-25. doi: 10.1111/adb.12259. Epub 2015 May 15. Addict Biol. 2016. PMID: 25975203
-
Targeting mGlu Receptors for Optimization of Antipsychotic Activity and Disease-Modifying Effect in Schizophrenia.Front Psychiatry. 2019 Feb 14;10:49. doi: 10.3389/fpsyt.2019.00049. eCollection 2019. Front Psychiatry. 2019. PMID: 30890967 Free PMC article. Review.
-
The role of mGlu receptors in susceptibility to stress-induced anhedonia, fear, and anxiety-like behavior.Int Rev Neurobiol. 2023;168:221-264. doi: 10.1016/bs.irn.2022.10.006. Epub 2022 Nov 25. Int Rev Neurobiol. 2023. PMID: 36868630 Review.
Cited by
-
Neuropharmacological Evidence Implicating Drug-Induced Glutamate Receptor Dysfunction in Affective and Cognitive Sequelae of Subchronic Methamphetamine Self-Administration in Mice.Int J Mol Sci. 2024 Feb 5;25(3):1928. doi: 10.3390/ijms25031928. Int J Mol Sci. 2024. PMID: 38339206 Free PMC article.
-
Targeting Neuroplasticity in Substance Use Disorders: Implications for Therapeutics.Annu Rev Pharmacol Toxicol. 2025 Jan;65(1):259-280. doi: 10.1146/annurev-pharmtox-061724-080548. Epub 2024 Dec 17. Annu Rev Pharmacol Toxicol. 2025. PMID: 39374445 Review.
-
Effects of systemic pretreatment with the NAALADase inhibitor 2-PMPA on oral methamphetamine reinforcement in C57BL/6J mice.Front Psychiatry. 2024 Apr 4;15:1297275. doi: 10.3389/fpsyt.2024.1297275. eCollection 2024. Front Psychiatry. 2024. PMID: 38638417 Free PMC article.
-
Post-methamphetamine working memory decline predicts relapse vulnerability in rats and is rescued by mGlu3 receptor activation.Psychopharmacology (Berl). 2025 Jul 18. doi: 10.1007/s00213-025-06847-2. Online ahead of print. Psychopharmacology (Berl). 2025. PMID: 40679605
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical